Production method

Details for Australian Patent Application No. 2004313694 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Rehse, Joachim; Grotjohann, Dirk; Berwe, Mathias; Thomas, Christian

Agent Davies Collison Cave

Pub. Number AU-B-2004313694

PCT Pub. Number WO2005/068456

Priority 102004002044.2 15.01.04 DE

Filing date 31 December 2004

Wipo publication date 28 July 2005

Acceptance publication date 2 June 2011

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2005/068456 Priority application(s): WO2005/068456

14 May 2009 Assignment before Grant

  Bayer HealthCare AG The application has been assigned to Bayer Schering Pharma Aktiengesellschaft

2 June 2011 Application Accepted

  Published as AU-B-2004313694

8 September 2011 Alteration of Name

  The name of the applicant has been altered to Bayer Pharma Aktiengesellschaft 2006 Amendments

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004313695-Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases

2004313693-Diaza-spiropiperidine derivatives